ACCELERON PHARMA INC. Form SC14D9C: Written communication by the subject company on a tender offer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2021-09-30: Form SC14D9C; Description SC14D9C; Document tm2128840d2_sc14d9c.htm.
- 2021-09-30: Form SC14D9C; Description ACCELERON PHARMA INC.; Document p21-2236sc14d9c.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2021-09-30 | SC14D9C | SC14D9C | tm2128840d2_sc14d9c.htm | |
| 2021-09-30 | SC14D9C | ACCELERON PHARMA INC. | p21-2236sc14d9c.htm |